EP PerMed - European Partnership for Personalised Medicine

Improving health outcomes within sustainable health systems through research, development, innovation and implementation of personalized medicine approaches for the benefit of patients, citizens and society is the vision of EP PerMed. This partnership promotes the joint programming of national and European research and innovation support activities that put the Strategic Research and Innovation Agenda for Personalized Medicine into action, through dedicated funding for research, development and innovation.

Personalized medicine is broadly understood as a medical model that uses the characterization of people's phenotypes and genotypes (e.g. molecular characterization, medical imaging, lifestyle data) to adjust the therapeutic strategy to each person at the right time, and/or to determine predisposition to diseases and/or to provide timely and appropriately targeted preventive care (according to the conclusions of the Council of the European Union on personalized medicine for patients - 2015/C 421/03).

EP PerMed brings together 62 institutions, including ministries, funding organizations and research institutes, from 29 countries, and is based on the results and experience of various international initiatives and projects in the field of personalized medicine, as well as more than 15 years of successful collaboration between many of the partners involved.

The FCT, the Agency for Clinical Research and Biomedical Innovation, the Centre's Regional Coordination and Development Commission and the Vice-Presidency of the Regional Government of the Azores, through the Regional Directorate for Science, Innovation and Development, are the Portuguese organizations that are part of EP PerMed.

This initiative has received funding from the European Union's Horizon Europe research and innovation program, grant agreement No. 101137129.